Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Objectives To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in institutional care and to evaluate these treatments with respect to change in cognitive performance. Design Randomised double blind (clinician, patient, outcomes assessor) placebo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ballard, Clive, Margallo-Lana, Marisa, Juszczak, Edmund, Douglas, Simon, Swann, Alan, Thomas, Alan, O'Brien, John, Everratt, Anna, Sadler, Stuart, Maddison, Clare, Lee, Lesley, Bannister, Carol, Elvish, Ruth, Jacoby, Robin
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group Ltd. 2005
Schlagworte:
Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC556156/
https://ncbi.nlm.nih.gov/pubmed/15722369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.38369.459988.8F
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge